US Patent 9415034 Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
Patent 9415034 was granted and assigned to National Defense Medical Center on August, 2016 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9415034 Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
